欢迎访问《标记免疫分析与临床》官方网站!
临床研究

CA19-9、增强MRI和PET/CT在胰腺癌诊断及分期中的价值

展开
  • 沈阳军区总医院核医学科,辽宁 沈阳 110840
王治国(1974-),男(汉),副主任技师。专业:核医学技术。

收稿日期: 2014-06-11

  修回日期: 2014-07-11

  网络出版日期: 2014-11-06

Clinical Value of CA19-9, Contrast-Enhanced MRI and PET-CT in the Diagnosis and Staging of Pancreatic Cancer

Expand
  • Department of Nuclear Medicine,General Hospital of Shenyang Military Area Command, Shenyang 110840, China

Received date: 2014-06-11

  Revised date: 2014-07-11

  Online published: 2014-11-06

摘要

目的 探讨CA19-9、增强MRI 和 PET/CT在胰腺癌诊断及分期中的价值。方法 回顾性分析沈阳军区总医院普外科2013年1月至2014年1月间收治的92例手术治疗的胰腺占位患者资料。术前均行 CA19-9检查、腹部增强MRI扫描及全身PET/CT扫描,以术后病理或临床综合评价诊断为标准,比较CA19-9、增强MRI和PET/CT在胰腺癌诊断及分期中的价值。结果 92例患者中,确诊胰腺癌82例,非胰腺癌10例。CA19-9检查、腹部增强MRI及全身PET/CT对胰腺癌诊断的灵敏度分别为78. 0%、86.6%和92.7%。PET/CT具有较高灵敏度,显著优于CA19-9,差异有统计学意义(P =0.008);PET/CT优于增强MRI,差异无统计学意义(P =0.200);在胰周淋巴结转移判断方面,增强MRI和PET/CT的灵敏度分别为46.9%、81.6%,二者差异有统计学意义( P =0.0003);在肝转移判断方面,增强MRI和PET/CT诊断的灵敏度分别为54.5%、72.7%,二者差异无统计学意义(P =0.66) 。结论 PET/CT对胰腺癌诊断有较高灵敏度,优于CA19-9、增强MRI;PET/CT有助于发现淋巴结和远处器官转移病灶,获得更加准确的术前分期,从而避免诊断性剖腹探查手术。由于仍然存在假阴性、假阳性,应该综合其他检查方法对疾病作全面分析来提高临床诊断准确性。

关键词: 胰腺癌; CA19-9; 增强MRI; PET/CT

本文引用格式

王治国,石庆学,郭 佳,左 峰,吴锐先,张宗鹏,张国旭 . CA19-9、增强MRI和PET/CT在胰腺癌诊断及分期中的价值[J]. 标记免疫分析与临床, 2014 , 21(5) : 507 . DOI: 10.11748/bjmy.issn.1006-1703.2014.05.004

Abstract

Objective To investigate the CA19-9, enhanced MRI and PET-CT value in the diagnosis and staging of pancreatic cancer. Methods A retrospective analysis of 92 patients with pancreatic placeholder admitted in our hospital was carried out. Preoperative CA19-9 inspection, abdominal enhanced MRI scans and whole body PET-CT scan were performed. The clinical value of CA19-9, enhanced MRI and PET-CT in the diagnosis and staging of pancreatic cancer were evaluated. Results Among 92 patients, 82 cases were diagnosed with pancreatic cancer and 10 cases with non-pancreatic cancer. The sensitivity of CA19-9 inspection, abdominal enhanced MRI and whole body PET-CT for the diagnosis of pancreatic cancer were 78.0%, 86.6% and 92.7 % respectively. PET-CT had a higher sensitivity and better than CA19-9 (P<0.01). PET-CT was superior to enhanced MRI but no statistically significant (P = 0.200). The sensitivity of enhanced MRI and PET-CT in the judgment of peripancreatic lymph node metastasis were 46.9% and 81.6% (P<0.001). The sensitivity of enhanced MRI and PET-CT in diagnosis of liver metastases were 54.5 % and 72.7 % without statistically significant (P = 0.66). PET-CT in the diagnosis of pancreatic cancer had a higher sensitivity than CA19-9 and enhanced MRI. Conclusion PET-CT could help to find the lymph nodes and distant organs metastasis, to obtain a more accurate preoperative staging, thus avoiding diagnostic laparotomy exploratory surgery. There is still false negative and false positive result for PET-CT, the comprehensive analysis of all inspection method results should be carried out to improve clinical diagnosis accuracy.
文章导航

/